How should healthcare organisations choose two-factor authentication for EPCS without disrupting prescribing workflows?

Choose a method that satisfies DEA requirements and fits the way prescribers actually work. The best option is the one that balances usability, compliance, and clinical speed in the settings where prescribing happens. In high-volume inpatient areas, biometrics may reduce friction. For remote prescribing, tokens can be more practical. If the method slows clinicians down, adoption will suffer and the programme is likely to stall.

Choosing an EPCS two-factor method without slowing prescribers

The right choice is the one that satisfies DEA requirements and fits the real prescribing environment. In practice, that means the second factor should be quick enough for high-frequency use, dependable in the clinical setting, and acceptable to prescribers who may be moving between workstations, wards, or remote locations. A compliant method that is awkward to use will often fail operationally.

For healthcare organisations, the method is not just an authentication control, it is part of the prescribing workflow. That means the best choice depends on where prescribers authenticate, how often they sign controlled-substance prescriptions, what devices they use, and whether the clinic, inpatient unit, or remote setting creates delays that would push users toward workarounds.

In high-volume bedside or inpatient workflows, methods that reduce typing and context switching are usually easier to sustain. That is why biometrics can be attractive where shared workstations and rapid sign-off are common, while token-based options may fit better for remote prescribing or lower-volume settings where carrying a token is not a burden. The goal is to make the secure path the path clinicians will actually take.

Why usability and compliance have to be designed together

EPCS is one of the few areas where authentication friction directly affects clinical throughput. If a prescriber has to stop, search for a device, re-enter credentials, or recover from repeated prompts, the control starts to compete with care delivery. Organisations should therefore test the method in the actual prescribing journey, not only against policy language or procurement requirements.

That testing should include the full path from login to signing, not just the factor itself. A method that works well for office-based prescribers may be a poor fit for inpatient teams, cross-cover clinicians, or remote users who need fast access during time-sensitive care. The real question is whether the authentication step preserves both assurance and clinical pace.

When a method is selected purely because it is technically compliant, teams often discover that clinicians route around it through shared devices, delayed signing, or excessive exception handling. The more the control interrupts the normal flow of prescribing, the more likely it is to be treated as a barrier instead of a safeguard.

What good looks like in a healthcare rollout

A workable EPCS deployment has a small number of qualities in common: the second factor is available when and where prescribing happens, the recovery process is clear, and prescribers do not need to rethink the process every time they move between locations. Strong healthcare identity guidance from Healthcare Identity Security Guide reinforces that EPCS has to be designed for clinical reality, including shared workstations and prescriber mobility.

Method selection also benefits from comparing user burden and phishing resistance together. MFA Guide is useful here because it helps teams distinguish between methods that are merely familiar and methods that are resilient against interception, fatigue, or token theft. For healthcare organisations, that matters because the least disruptive option is not always the safest one.

For organisations that want a broader implementation lens, Workforce Identity Security Guide is relevant because it connects authentication choice to federation, recovery, and day-to-day usability. Those are the same factors that determine whether prescribers can use EPCS without repeated exceptions or support calls.

External guidance also helps anchor the control to recognised identity assurance expectations. NIST SP 800-63 Digital Identity Guidelines is the most useful external reference for comparing authenticator strength, assurance, and phishing-resistant options when designing a method that clinicians can use repeatedly. It is especially helpful when evaluating whether the chosen factor supports the assurance level the organisation believes it has.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

NIST SP 800-63, NIST CSF 2.0 and OWASP ASVS set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.

Framework	Control / Reference	Relevance
NIST SP 800-63	Digital Identity Guidelines	EPCS 2FA choice depends on authenticator assurance and phishing resistance.
Recommendation — Use authenticated assurance levels to select a factor clinicians can use repeatedly.
NIST CSF 2.0	PR.AA-05 — Authenticator Management	The question centers on selecting and operating authenticators for controlled access.
Recommendation — Select and manage authenticators that balance assurance with workflow fit.
ISO/IEC 27001:2022	A.5.17 — Authentication information	EPCS depends on properly managed authentication information and usable sign-in controls.
Recommendation — Protect authentication information and ensure the chosen factor is operationally sustainable.
OWASP ASVS	V6 — Authentication	The question is about choosing an authentication method and its usability trade-offs.
Recommendation — Validate the authentication approach against usability and assurance requirements.

Practitioner Guidance

What to prioritise: Test the method in the prescribing context first, then decide. A technically strong factor that adds seconds at every sign event can become the wrong choice if it slows high-volume prescribers more than it improves assurance.

What to verify: Confirm that the chosen method works cleanly across the devices and locations where EPCS actually happens, including shared workstations, inpatient units, and remote sessions. Also verify the recovery path, because authentication recovery failures often create more workflow disruption than the factor itself.

Decision rule: If prescribers authenticate frequently and speed is critical, favour the option that minimises friction while still meeting the required assurance bar. If the workflow is more remote or intermittent, a portable method may be easier to sustain even if it is less seamless in the moment.

Common mistake: Treating compliance as the finish line. A control that clinicians avoid, bypass, or complain about is usually a sign that the design did not match the actual workflow.

Practitioner takeaway: For EPCS, the best two-factor method is the one that preserves both prescribing speed and usable assurance, because in healthcare the control only works if clinicians can tolerate it at operational tempo.